Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Illinois Tool Works logoIllinois Tool Works ITW

The company said organic revenue decreased 0.4% in Q2 and 1.0% in the year-to-date period. Operating revenue increased in Q2 due to the effect of foreign currency translation, and declined in the year-to-date period due to lower organic revenue and the effect of foreign currency translation, the company explained.

10-QQuarterly reportFiled Period of report Summary published (UTC)

Key points

AI summary
  1. The company said organic revenue decreased 0.4% in Q2 and 1.0% in the year-to-date period. Operating revenue increased in Q2 due to the effect of foreign currency translation, and declined in the year-to-date period due to lower organic revenue and the effect of foreign currency translation, the company explained.

  2. The company said operating income of $1.1 billion increased 1.2% in Q2 and operating margin was 26.3%, up 10 basis points. In the year-to-date period, operating income of $2.0 billion declined 7.4%, or declined 2.2% excluding the $117 million favorable impact of the Q1 2024 LIFO accounting method change, the company said.

  3. The company said on April 2, 2025 the United States government announced additional tariffs. It said it is well positioned to minimize the impact because its businesses generally manufacture products in the markets where they are sold and it expects to recover the increased cost of tariffs through price increases, but current tariff policies have introduced additional uncertainty and may negatively impact overall demand from its customers.

  4. The company said as of June 30, 2025 it held cash and cash equivalents of $788 million and had no outstanding borrowings under its $3.0 billion revolving credit facility. It repurchased approximately 1.5 million shares in Q2 for approximately $375 million, and the remaining authorization to repurchase shares under the 2023 program is approximately $2.7 billion.

Key figures

Quarter ended June 30, 2025

Revenue
$4.1B
Operating income
$1.1B
Net income
$755M
EPS
$2.58

From the XBRL financial data filed with the SEC · not processed by AI.

Summary

AI-written

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

Q2 Operating Revenue and Organic Revenue

The company said organic revenue decreased 0.4% in Q2 and 1.0% in the year-to-date period. Operating revenue increased in Q2 due to the effect of foreign currency translation, and declined in the year-to-date period due to lower organic revenue and the effect of foreign currency translation, the company explained.

Source · Based on the MD&A text of the filing

Operating Income and Operating Margin

The company said operating income of $1.1 billion increased 1.2% in Q2 and operating margin was 26.3%, up 10 basis points. In the year-to-date period, operating income of $2.0 billion declined 7.4%, or declined 2.2% excluding the $117 million favorable impact of the Q1 2024 LIFO accounting method change, the company said.

Source · Based on the MD&A text of the filing

Tariffs and Company Response

The company said on April 2, 2025 the United States government announced additional tariffs. It said it is well positioned to minimize the impact because its businesses generally manufacture products in the markets where they are sold and it expects to recover the increased cost of tariffs through price increases, but current tariff policies have introduced additional uncertainty and may negatively impact overall demand from its customers.

Source · Based on the MD&A text of the filing

Liquidity and Share Repurchases

The company said as of June 30, 2025 it held cash and cash equivalents of $788 million and had no outstanding borrowings under its $3.0 billion revolving credit facility. It repurchased approximately 1.5 million shares in Q2 for approximately $375 million, and the remaining authorization to repurchase shares under the 2023 program is approximately $2.7 billion.

Source · Based on the MD&A text of the filing

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.